View DividendAton マネジメントマネジメント 基準チェック /24現在、CEO に関する十分な情報がありません。主要情報Ayikoele Atayi最高経営責任者€47.5k報酬総額CEO給与比率100.00%CEO在任期間2.5yrsCEOの所有権n/a経営陣の平均在職期間データなし取締役会の平均在任期間2.5yrs経営陣の近況お知らせ • May 25Aton, Annual General Meeting, Jun 30, 2026Aton, Annual General Meeting, Jun 30, 2026. Location: 850 boulevard sebastien brant, illkirch graffenstaden Franceお知らせ • May 21Aton, Annual General Meeting, Jun 30, 2025Aton, Annual General Meeting, Jun 30, 2025. Location: 850 boulevard sebastien brant, illkirch graffenstaden Franceすべての更新を表示Recent updatesNew Risk • 14hNew major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.78m (US$9.99m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (159% average daily change). Earnings have declined by 20% per year over the past 5 years. Revenue is less than US$1m (€657k revenue, or US$748k). Market cap is less than US$10m (€8.78m market cap, or US$9.99m). Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).お知らせ • May 25Aton, Annual General Meeting, Jun 30, 2026Aton, Annual General Meeting, Jun 30, 2026. Location: 850 boulevard sebastien brant, illkirch graffenstaden FranceNew Risk • May 19New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (162% average daily change). Earnings have declined by 20% per year over the past 5 years. Revenue is less than US$1m (€657k revenue, or US$763k). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Market cap is less than US$100m (€12.4m market cap, or US$14.4m).New Risk • Nov 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 38% per year over the past 5 years. Revenue is less than US$1m (€614k revenue, or US$714k). Market cap is less than US$10m (€6.04m market cap, or US$7.01m). Minor Risk Latest financial reports are more than 6 months old (reported December 2024 fiscal period end).お知らせ • May 21Aton, Annual General Meeting, Jun 30, 2025Aton, Annual General Meeting, Jun 30, 2025. Location: 850 boulevard sebastien brant, illkirch graffenstaden FranceNew Risk • Nov 14New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.42m (US$9.91m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (15% average weekly change). Shareholders have been substantially diluted in the past year (162% increase in shares outstanding). Market cap is less than US$10m (€9.42m market cap, or US$9.91m).New Risk • Jul 24New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 163% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (61% average daily change). Shareholders have been substantially diluted in the past year (163% increase in shares outstanding). Minor Risk Market cap is less than US$100m (€9.49m market cap, or US$10.3m).New Risk • May 19New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 53% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (47% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Market cap is less than US$10m (€4.00m market cap, or US$4.35m).New Risk • Nov 07New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.44m (US$9.02m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (13% average weekly change). Market cap is less than US$10m (€8.44m market cap, or US$9.02m). Minor Risk Shareholders have been diluted in the past year (13% increase in shares outstanding).New Risk • Oct 26New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (9.1% average weekly change). Minor Risks Shareholders have been diluted in the past year (13% increase in shares outstanding). Market cap is less than US$100m (€13.3m market cap, or US$14.0m).New Risk • Jul 23New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 11% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Shareholders have been diluted in the past year (11% increase in shares outstanding). Market cap is less than US$100m (€15.9m market cap, or US$17.7m).お知らせ • May 07Hybrigenics Société Anonyme announced that it has received fundingHybrigenics Société Anonyme (ENXTPA:ALHYG) announced that it has received a round of funding on May 6, 2021. The company has issued common stock in the transaction.Is New 90 Day High Low • Feb 25New 90-day high: €0.30The company is up 47% from its price of €0.20 on 27 November 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Biotechs industry, which is up 7.0% over the same period.Is New 90 Day High Low • Feb 10New 90-day high: €0.23The company is up 31% from its price of €0.18 on 11 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Biotechs industry, which is up 11% over the same period.Is New 90 Day High Low • Jan 20New 90-day high: €0.22The company is up 19% from its price of €0.19 on 22 October 2020. The German market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Biotechs industry, which is up 9.0% over the same period.Is New 90 Day High Low • Nov 25New 90-day high: €0.21The company is up 18% from its price of €0.18 on 26 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Biotechs industry, which is down 8.0% over the same period.CEO報酬分析Aton の収益と比較して、Ayikoele Atayi の報酬はどのように変化したか？日付総報酬給与会社業績Jun 30 2025n/an/a-€116kMar 31 2025n/an/a-€608kDec 31 2024€48k€48k-€1mSep 30 2024n/an/a-€3mJun 30 2024n/an/a-€16mMar 31 2024n/an/a-€17mDec 31 2023€95k€95k-€8mDec 31 2022€95k€95k-€564k報酬と市場: Ayikoeleの 総報酬 ($USD 54.06K ) は、 German市場 ($USD 427.35K ) の同様の規模の企業の平均を下回っています。報酬と収益: Ayikoeleの報酬は、過去 1 年間の会社の業績と一致しています。CEOAyikoele Atayi 2.5yrs在職期間€47,500報酬Ms. Ayikoele Atayi is General Manager of Aton and also serves as Chair of the Board of Directors since December 21, 2023.取締役名称ポジション在職期間報酬所有権Ayikoele AtayiGM & Chair of the Board of Directors2.5yrs€47.50kデータなしHadrien LanvinDeputy CEO & Director2.5yrsデータなしデータなしEnrico BastianelliIndependent Director2.5yrs€2.00kデータなしPierre EftekhariDirector4.8yrsデータなし3.65% € 320.4kVirginie MiathIndependent Director2.5yrsデータなしデータなしもっと見る2.5yrs平均在職期間経験豊富なボード: 3HBの 取締役会 は 経験豊富 ではない ( 2.5年の平均在任期間) ため、新しい取締役会が必要であると考えられます。View Ownership企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/23 12:14終値2026/06/23 00:00収益2025/06/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Aton 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 25Aton, Annual General Meeting, Jun 30, 2026Aton, Annual General Meeting, Jun 30, 2026. Location: 850 boulevard sebastien brant, illkirch graffenstaden France
お知らせ • May 21Aton, Annual General Meeting, Jun 30, 2025Aton, Annual General Meeting, Jun 30, 2025. Location: 850 boulevard sebastien brant, illkirch graffenstaden France
New Risk • 14hNew major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.78m (US$9.99m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (159% average daily change). Earnings have declined by 20% per year over the past 5 years. Revenue is less than US$1m (€657k revenue, or US$748k). Market cap is less than US$10m (€8.78m market cap, or US$9.99m). Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).
お知らせ • May 25Aton, Annual General Meeting, Jun 30, 2026Aton, Annual General Meeting, Jun 30, 2026. Location: 850 boulevard sebastien brant, illkirch graffenstaden France
New Risk • May 19New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (162% average daily change). Earnings have declined by 20% per year over the past 5 years. Revenue is less than US$1m (€657k revenue, or US$763k). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Market cap is less than US$100m (€12.4m market cap, or US$14.4m).
New Risk • Nov 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 38% per year over the past 5 years. Revenue is less than US$1m (€614k revenue, or US$714k). Market cap is less than US$10m (€6.04m market cap, or US$7.01m). Minor Risk Latest financial reports are more than 6 months old (reported December 2024 fiscal period end).
お知らせ • May 21Aton, Annual General Meeting, Jun 30, 2025Aton, Annual General Meeting, Jun 30, 2025. Location: 850 boulevard sebastien brant, illkirch graffenstaden France
New Risk • Nov 14New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.42m (US$9.91m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (15% average weekly change). Shareholders have been substantially diluted in the past year (162% increase in shares outstanding). Market cap is less than US$10m (€9.42m market cap, or US$9.91m).
New Risk • Jul 24New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 163% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (61% average daily change). Shareholders have been substantially diluted in the past year (163% increase in shares outstanding). Minor Risk Market cap is less than US$100m (€9.49m market cap, or US$10.3m).
New Risk • May 19New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 53% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (47% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Market cap is less than US$10m (€4.00m market cap, or US$4.35m).
New Risk • Nov 07New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.44m (US$9.02m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (13% average weekly change). Market cap is less than US$10m (€8.44m market cap, or US$9.02m). Minor Risk Shareholders have been diluted in the past year (13% increase in shares outstanding).
New Risk • Oct 26New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (9.1% average weekly change). Minor Risks Shareholders have been diluted in the past year (13% increase in shares outstanding). Market cap is less than US$100m (€13.3m market cap, or US$14.0m).
New Risk • Jul 23New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 11% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Shareholders have been diluted in the past year (11% increase in shares outstanding). Market cap is less than US$100m (€15.9m market cap, or US$17.7m).
お知らせ • May 07Hybrigenics Société Anonyme announced that it has received fundingHybrigenics Société Anonyme (ENXTPA:ALHYG) announced that it has received a round of funding on May 6, 2021. The company has issued common stock in the transaction.
Is New 90 Day High Low • Feb 25New 90-day high: €0.30The company is up 47% from its price of €0.20 on 27 November 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Biotechs industry, which is up 7.0% over the same period.
Is New 90 Day High Low • Feb 10New 90-day high: €0.23The company is up 31% from its price of €0.18 on 11 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Biotechs industry, which is up 11% over the same period.
Is New 90 Day High Low • Jan 20New 90-day high: €0.22The company is up 19% from its price of €0.19 on 22 October 2020. The German market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Biotechs industry, which is up 9.0% over the same period.
Is New 90 Day High Low • Nov 25New 90-day high: €0.21The company is up 18% from its price of €0.18 on 26 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Biotechs industry, which is down 8.0% over the same period.